Shares of Achieve Life Sciences Inc. (ACHV) are up over 30% in pre-market trading on Friday, following encouraging final data from its phase I/II multi-dose, pharmacokinetic and pharmacodynamics clinical study of Cytisinicline in smokers.
Original Article: Here's Why Achieve Life Sciences Is Soaring